FLRT3 interacts with latrophilins (e.g., LPHN3) to regulate glutamatergic synapse density:
Mechanism: FLRT3’s LRR domain binds the olfactomedin (OLF) domain of LPHN3 with high affinity () .
Experimental evidence:
| Parameter | Control (VEGF-A) | FLRT3 siRNA (VEGF-A) |
|---|---|---|
| Survival | 100% | 70 ± 5% |
| Wound Healing | Baseline | +20% migration rate |
| Tube Formation | High density | Reduced density |
FLRT3 produced in HEK293 cells is widely used for structural and functional studies:
| Product Code | Source | Purity | Key Features | Applications |
|---|---|---|---|---|
| PRO-2805 | HEK293 | >95% | His-tagged, aa 29–528 | Binding assays, structural studies |
| PRO-2181 | HEK293 | >95% | His-tagged, full-length | Cell adhesion assays, signaling studies |
Glycosylation: HEK293-expressed FLRT3 retains post-translational modifications critical for biological activity .
Binding studies: Surface plasmon resonance (SPR) confirmed direct FLRT3-LPHN3 interaction () .
Functional knockdown: shRNA and siRNA tools reduce FLRT3 expression by >70% in neurons and ECs .
Immunofluorescence: Prox1 staining identifies FLRT3-expressing dentate granule cells in hippocampal cultures .
HEK293 Cells.
KSCPSVCRCD AGFIYCNDRF LTSIPTGIPE DATTLYLQNN QINNAGIPSD LKNLLKVERI YLYHNSLDEF PTNLPKYVKE LHLQENNIRT ITYDSLSKIP YLEELHLDDN SVSAVSIEEG AFRDSNYLRL LFLSRNHLST IPWGLPRTIE ELRLDDNRIS TISSPSLQGL TSLKRLVLDG NLLNNHGLGD KVFFNLVNLT ELSLVRNSLT AAPVNLPGTN LRKLYLQDNH INRVPPNAFS
YLRQLYRLDM SNNNLSNLPQ GIFDDLDNIT QLILRNNPWY CGCKMKWVRD WLQSLPVKVN VRGLMCQAPE KVRGMAIKDL NAELFDCKDS GIVSTIQITT AIPNTVYPAQ GQWPAPVTKQ PDIKNPKLTK DHQTTGSPSR KTITITVKSV TSDTIHISWK LALPMTALRL SWLKLGHSPA FGSITETIVT GERSEYLVTA LEPDSPYKVC MVPMETSNLY LFDETPVCIE TETAPLRMYN
PTTTLNREQE KEPYKNPNLP HHHHHH.
Human FLRT3 is an 85-95 kDa type I transmembrane glycoprotein synthesized as a 649 amino acid precursor. Its structure includes a 28 amino acid signal sequence, a 500 amino acid extracellular domain (ECD), a 21 amino acid transmembrane segment, and a 100 amino acid cytoplasmic region. The ECD contains 10 N-terminal leucine-rich repeats (LRRs) flanked by cysteine-rich areas, and a juxtamembrane fibronectin type III domain. This complex structure facilitates FLRT3's diverse protein-protein interactions and signaling capabilities .
FLRT3 serves as a multifunctional protein in neural development and function. It participates in cell-cell adhesion, cell migration, and axon guidance, exerting either attractive or repulsive roles depending on its interaction partners. It plays a crucial role in the spatial organization of brain neurons and promotes neurite outgrowth. Significantly, FLRT3 functions as an endogenous postsynaptic ligand for latrophilins (including LPHN3), with this interaction being essential for glutamatergic synapse development and maintenance .
Recombinant human FLRT3 protein can be expressed in HEK293 cells as a fragment spanning amino acids 1-528, typically with a C-terminal 6-His tag for purification purposes. When properly expressed, the protein achieves >98% purity with endotoxin levels below 1 EU/μg. The recombinant protein corresponds specifically to the extracellular portion (Lys29-Pro528) of FLRT3, making it suitable for investigating extracellular interactions without membrane constraints .
The human FLRT3 extracellular domain exhibits high evolutionary conservation, sharing 96%, 96%, 97%, 97%, 98%, and 81% amino acid sequence identity with mouse, rat, canine, bovine, equine, and Xenopus FLRT3 ECDs, respectively. Within the human FLRT family, the FLRT3 ECD shares 61% amino acid identity with FLRT2 and 48% with FLRT1, indicating functional specialization within this protein family while maintaining core structural elements .
Several complementary approaches can be employed to investigate FLRT3-LPHN3 interactions:
Affinity chromatography and mass spectrometry: For identifying binding partners and interaction domains.
Direct binding assays: Using purified proteins (FLRT3-His and ecto-LPHN3-Fc) in cell-free systems to confirm direct interactions and eliminate potential co-receptor involvement.
Surface plasmon resonance (SPR): For quantitative characterization of binding affinity between FLRT3 and LPHN3 ectodomains.
Cellular binding assays: Expressing FLRT3-myc in HEK293 cells and applying ecto-LPHN3-Fc to assess binding specificity compared to control proteins.
Co-immunoprecipitation: To verify protein-protein interactions in cellular contexts.
Co-culture systems: LPHN3-expressing neurons cultured with FLRT3-expressing HEK293 cells to observe protein clustering at contact sites .
Three distinct experimental approaches have proven effective for perturbing FLRT3-LPHN3 complexes:
Competition with soluble ectodomains: Application of excess soluble ecto-LPHN3-Fc protein to competitively disrupt endogenous LPHN3 complexes.
shRNA knockdown of FLRT3: Electroporation of neurons with FLRT3-targeting shRNA (shFlrt3), with validation through rescue experiments using shRNA-resistant FLRT3 constructs.
shRNA knockdown of LPHN3: Targeted reduction of presynaptic LPHN3 expression.
All three approaches result in reduced glutamatergic synapse density, supporting the critical role of FLRT3-LPHN3 interaction in synapse formation and maintenance .
Following genetic or pharmacological manipulation of FLRT3, several functional assays can assess the resulting phenotypes:
Immunofluorescence analysis: Quantifying synaptic puncta density and size using markers like PSD95 and synapsin.
Electrophysiology: Recording miniature excitatory postsynaptic currents (mEPSCs) to measure both frequency (reflecting synapse number) and amplitude (reflecting synaptic strength).
In vivo manipulations: Reducing FLRT3 levels with shRNA in vivo to evaluate effects on afferent input strength and dendritic spine numbers in specific neuronal populations like dentate granule cells.
Heterologous cell assays: Testing whether FLRT3 or LPHN3 expression in HEK293 cells can induce pre- and postsynaptic differentiation in contacting neurons .
FLRT3 plays a critical role in glutamatergic synapse development through multiple mechanisms:
FLRT3 functions as a postsynaptic adhesion molecule that interacts with presynaptic latrophilins (including LPHN3) across the synaptic cleft.
Knockdown of FLRT3 with shRNA significantly reduces excitatory synapse density in cultured hippocampal neurons.
This reduction in synapse density correlates with decreased miniature excitatory postsynaptic current (mEPSC) frequency.
In vivo reduction of FLRT3 levels decreases both afferent input strength and dendritic spine numbers in dentate granule cells.
The FLRT3-LPHN3 interaction appears to positively regulate synapse number, as disruption of this interaction through multiple approaches consistently leads to reduced glutamatergic synapse density .
FLRT3 exhibits remarkable functional duality through distinct molecular surfaces that mediate opposing cellular responses:
Homophilic adhesion: FLRT3 can interact with FLRT3 molecules on adjacent cells to promote cell-cell adhesion.
Heterophilic repulsion: Simultaneously, FLRT3 can interact with Unc5 receptors to mediate repulsive guidance.
Integrative signaling: Neurons expressing both Unc5 and FLRT integrate these adhesive and repulsive signals from FLRT3, resulting in a balanced response that directs precise neuronal positioning and connectivity.
Structural basis: Crystal structures of FLRT proteins and their complexes with Unc5 receptors have revealed that these opposing functions are mediated by structurally distinct binding interfaces .
FLRT3's diverse functions are mediated by its distinct structural domains:
Leucine-rich repeat (LRR) domain:
Mediates homophilic FLRT-FLRT interactions
Responsible for localization in areas of cell contact
Facilitates homotypic cell-cell association
Involved in binding to Unc5 receptors
Fibronectin type III domain:
Responsible for binding to FGF receptors
Regulates FGF signaling during development
Juxtamembrane linker region:
Contains a metalloprotease cleavage site
Allows proteolytic shedding of the FLRT ectodomain, which can modulate neuronal migration
These domain-specific functions allow FLRT3 to participate in multiple cellular processes through different molecular interactions .
FLRT3 plays multiple critical roles in cortical development:
Migration regulation: FLRT3 directs both radial migration and tangential spread of cortical neurons.
Adhesion-repulsion balance: FLRT proteins fine-tune adhesion and repulsion between cells migrating through the neocortex.
Integrative signaling: FLRT3 can trigger both adhesive and repulsive signals in the same receiving cell, leading to an integrative response that precisely positions neurons.
Proteolytic regulation: Similar to FLRT2, proteolytic shedding of FLRT3 may modulate migration of cortical neurons expressing Unc5 receptors .
FLRT3 is actively involved in vascular system development:
Retinal vascularization: FLRT3 specifically controls the formation of blood vessels in the retina.
Guidance mechanisms: Vascular cells are guided by FLRT using structurally conserved mechanisms similar to those employed in neuronal guidance.
Developmental regulation: As part of the FLRT family (FLRT1-3), FLRT3 functions as a regulator of early embryonic and vascular development.
These findings highlight the parallel mechanisms employed in neuronal and vascular patterning, with FLRT3 serving as a key signaling molecule in both systems .
FLRT3 expression exhibits spatiotemporal regulation throughout development and in response to injury:
Developmental expression:
Located in somitic regions on dermatomyotomal muscle precursors and myotomal cells before their migration
Expressed at the midbrain/hindbrain boundary and in the apical ectodermal ridge
Genetic deletion in mouse embryos leads to defective headfold fusion and endoderm migration
Postnatal expression:
For optimal experimental results with recombinant FLRT3:
Formulation: Recombinant human FLRT3 protein is typically supplied lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution: It should be reconstituted at 200 μg/mL in sterile PBS.
Shipping and receipt: The product is shipped at ambient temperature but should be stored immediately upon receipt at the recommended temperature.
Storage conditions: Use a manual defrost freezer and avoid repeated freeze-thaw cycles to maintain protein integrity.
Carrier considerations: For applications where the presence of BSA could interfere, carrier-free (CF) versions are available. Otherwise, BSA-containing formulations provide enhanced stability and longer shelf-life .
Rigorous control experiments are crucial for validating FLRT3-LPHN3 interaction studies:
Binding specificity controls:
Test binding of control Fc proteins alongside ecto-LPHN3-Fc
Verify that ecto-LPHN3-Fc does not bind to cells expressing unrelated proteins (e.g., LRRTM2)
Confirm binding of ecto-LPHN3-Fc to all FLRT isoforms (FLRT1-3)
Cell-free binding assays:
Perform precipitation experiments with purified proteins to eliminate the possibility that unknown co-receptors mediate the interaction
Rescue experiments:
When using shRNA knockdown, include rescue experiments with shRNA-resistant FLRT3 constructs to confirm specificity
Multiple interference approaches:
Several quantitative approaches can precisely measure FLRT3's impact on synapse formation:
Synaptic puncta analysis:
Immunofluorescence quantification of synaptic marker density (number of puncta per unit length of dendrite)
Measurement of synaptic puncta size (area)
Co-localization analysis with pre- and postsynaptic markers
Electrophysiological measurements:
mEPSC frequency analysis to assess functional synapse numbers
mEPSC amplitude measurements to evaluate synaptic strength
Structural analysis:
Quantification of dendritic spine numbers in vivo after FLRT3 manipulation
Assessment of afferent input strength to determine functional connectivity
These complementary approaches provide a comprehensive assessment of both structural and functional aspects of synapse formation regulated by FLRT3 .
The FLRT3 gene encodes a transmembrane cell-adhesion protein. The protein structure includes a cluster of leucine-rich repeats and one fibronectin type III domain within its extracellular region . These structural features are similar to small leucine-rich proteoglycans found in the extracellular matrix .
FLRT3 is expressed in many tissues and plays a crucial role in various biological processes. It functions in cell-cell adhesion, cell migration, and axon guidance . Depending on its interaction partners, FLRT3 can exert either attractive or repulsive roles. For instance, it interacts with ADGRL3 and other latrophilins to mediate cell-cell adhesion . Additionally, FLRT3 is involved in the spatial organization of brain neurons and vascular development in the retina .
FLRT3 has been associated with several diseases, including Hypogonadotropic Hypogonadism 21 and Kallmann Syndrome . It also plays a role in neuropathic pain. Increased expression of FLRT3 in the dorsal root ganglion has been shown to induce neuropathic pain in rats . This suggests that FLRT3 is involved in the regulation of neuronal excitability and pain sensitization following nerve injury .
Research on FLRT3 continues to uncover its diverse roles in cell adhesion, migration, and signaling. The human recombinant form of FLRT3, produced in HEK cells, is used in various studies to understand its function and potential therapeutic applications.